NIAGEN BIOSCIENCE, INC. Operating Leases, Future Minimum Payments, Due in Rolling Year Two
NIAGEN BIOSCIENCE, INC. (NAGE) had Operating Leases, Future Minimum Payments, Due in Rolling Year Two of $263.00 thousand as of 2020-12-31, per its 10-K filed 2021-03-12.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwo · last filed 2021-03-12
- 2020-12-31: Operating Leases, Future Minimum Payments, Due in Rolling Year Two $263.00K.
- 2020-09-30: Operating Leases, Future Minimum Payments, Due in Rolling Year Two $316.00K.
| Period end | Operating Leases, Future Minimum Payments, Due in Rolling Year Two |
|---|---|
| 2020-12-31 | $263.00K 10-K · filed 2021-03-12 |
| 2020-09-30 | $316.00K 10-Q · filed 2020-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |